Painless digestive endoscopy
Conditions
Interventions
Group A :Butorphanol tartrate 0.6mg combined with propofol 1.5-2mg/kg
Group B :Butorphanol tartrate 0.6mg combined with remazolam 0.2mg/kg
Group C :Butorphanol tartrate 0.6mg combined with remazolam 0.3mg/kg
Sponsors
Yancheng First People's Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. The age of 30-65 is not limited to men and women; 2. Patients with BMI of 18-30kg / m2; 3. Patients with ASA grade I or II; 4. Patients whose estimated operation time is less than 30 minutes; 5. All patients signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients allergic to benzodiazepines; 2. Preoperative evaluation of patients with difficult airway (Mallampati grade >= grade III) or sleep apnea syndrome; 3. Patients with previous history of angina pectoris and arrhythmia; 4. Patients with long-term use of sedative hypnotics; 5. Other circumstances in which the researcher judged that the patient was not suitable to participate in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anesthesia effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Pulse oxygen saturation;Heart rate;BIS;The injection pain;Nausea and vomiting;drowsiness;Full wake time;Narcotic dosage;Dosing frequency; | — |
Countries
China
Contacts
Public ContactYingying Zhao
Yancheng Clinical College affiliated to Xuzhou Medical University
Outcome results
None listed